P PRIMESTOCKFINDER.COM

EVE Shares EVE Health Group Limited

ACCUMULATE ASX · ASX
$0.01 +18.18% Prices as of close 2026-10-27

Energy-adjacent resource optionality provides speculative upside from asset development progress.

  • ▸Very small-cap catalyst profile with limited liquidity.
  • ▾Below 50-day MA (-16.24%)
  • ▸Volume 2.39× average — accumulation

Trend: EVE is trading below the 50-day average (-35.00%), RSI 56 — neutral momentum, with a 3-month return of -23.53%.

Valuation & quality: EVE Health Group Limited trades on price-to-book 1.18; fundamentals show net margin -164.0%, return on equity -50.4%, revenue growth -28.6% year on year.

Our screen: ACCUMULATE (score 1) — Energy-adjacent resource optionality provides speculative upside from asset development progress.

Computed from end-of-day data; not personal advice.

0.03 0.01 FebMarAprMayJunJulAugSepOct
Daily close, 2026-02-08 → 2026-10-27 (AUD). Range 0.01 – 0.03.
Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
+0.00%+50.00%-33.30%+0.00%+0.00%-50.00%+0.00%+0.00%
Market cap
$4.6M
EPS (ttm)
$0.00
Price / book
1.18
Beta
0.40
Net margin
-164.0%
ROE
-50.4%
Revenue growth
-28.6%
Revenue (ttm)
$1.2M
Free cash flow
$-1,042,438
52-wk range
$0.01 – $0.03
Volume
1,020,319
Avg volume (3m)
456,105
RSI (14)
56.3
vs 50-day MA
-35.00%
1-mo return
-18.75%
3-mo return
-23.53%
Volume z-score
11.35

EVE Health Group Limited, a life sciences and healthcare company, engages in the development and commercialization of pharmaceutical products in Australia. It operates in two segments, Meluka (Branded Wellness Consumer Products) and Nextract (Pharmaceutical Products and Intellectual Property).

Sector: Consumer Defensive · Industry: Packaged Foods · Australia · Website

Browse: all ASX stocks · Energy picks · today's movers

General information only (Australia). This is general information, not financial product advice. It doesn't consider your objectives, financial situation or needs — consider its appropriateness and seek licensed advice before acting. Not a recommendation to buy or sell any financial product.

Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.